文档介绍：INTERNATIONAL DIABETES FEDERATION, 2005 Clinical Guidelines Task Force
Global Guideline
for Type 2 Diabetes
Website and other versions of this document
This document is also available at
Versions of this document aimed at other audiences are
planned, in particular a series of articles in Diabetes Voice ((2006).2006).
Correspondence, and related literature from IDF
Correspondence to: Professor Philip Home, SCMS-Diabetes,
Medical School, Framlington Place, Newcastle upon Tyne,
NE2 4HH, UK. philip.******@
Other IDF publications, including Guide for Guidelines, are
available from , or from the IDF Executive Offi ce:
International Diabetes Federation, Avenue Emile De Mot 19,
B-1000 Brussels, Belgium. communications@
Acknowledgements, and sponsors’ duality
of interest
This activity was supported by unrestricted educational
grants from:
Eli Lilly
GlaxoSmithKline
Merck Inc (MSD)
Merck Santé
Novo Nordisk
Pfi zer Inc
Roche Diagnostics
Sanofi-Aventis
Takeda.
panies did not take part in the development
of the guideline. However, these and mercial
organizations on IDF’munications list were invited
to ments on draft versions of the guideline
(see Methodology).
Sylvia Lion of Eli Lilly is also thanked for providing
organizational support for the meeting of the Guidelines
Group.
Citation
IDF Clinical Guidelines Task Force. Global guideline for Type 2
diabetes. Brussels: International Diabetes Federation, 2005.
Copyright
All rights reserved. No part of this publication may be
reproduced or transmitted in any form or by any means
without the written prior permission of the International
Diabetes Federation (IDF). Requests to reproduce or
translate IDF publications should be addressed to
munications, Avenue Emile de Mot 19,
B-1000 Brussels, by fax at +32-2-5385114, or
by e-mail munications@
© International Diabetes Federation, 2005
ISBN 2-930229-43-8
2 Global Guideline for Type 2 Diabetes
Preface